Daewoong Pharmaceutical announced that they received approval of NABOTA from Thai Food and Drug Administration last month
On June 9, Daewoong Pharmaceutical announced that they received approval of NABOTA from Thai Food and Drug Administration (TFDA) last month.
The company plans to conduct a launching symposium targeting 300 experts and VIPs in Thailand starting from coming August, and plans to expand its market s...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
